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Background: Several translational studies have identified the differential role between saturated and unsaturated
fatty acids at cardiovascular level. However, the molecular mechanisms that support the protective role of oleate in
cardiovascular cells are poorly known. For these reasons, we studied the protective role of oleate in the insulin
resistance and in the atherosclerotic process at cellular level such as in cardiomyocytes (CMs), vascular smooth
muscle cells (VSMCs) and endothelial cells (ECs).
Methods: The effect of oleate in the cardiovascular insulin resistance, vascular dysfunction, inflammation, proliferation
and apoptosis of VSMCs were analyzed by Western blot, qRT-PCR, BrdU incorporation and cell cycle analysis.
Results: Palmitate induced insulin resistance. However, oleate not only did not induce cardiovascular insulin resistance
but also had a protective effect against insulin resistance induced by palmitate or TNFα. One mechanism involved
might be the prevention by oleate of JNK-1/2 or NF-κB activation in response to TNF-α or palmitate. Oleate reduced
MCP-1 and ICAM-1 and increased eNOS expression induced by proinflammatory cytokines in ECs. Furthermore, oleate
impaired the proliferation induced by TNF-α, angiotensin II or palmitate and the apoptosis induced by TNF-α or
thapsigargin in VSMCs.
Conclusions: Our data suggest a differential role between oleate and palmitate and support the concept of the
cardioprotector role of oleate as the main lipid component of virgin olive oil. Thus, oleate protects against
cardiovascular insulin resistance, improves endothelial dysfunction in response to proinflammatory signals and
finally, reduces proliferation and apoptosis in VSMCs that may contribute to an ameliorated atherosclerotic
process and plaque stability.
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Elevated circulating levels of saturated free fatty acids
(SFAs; e.g. palmitate) induce inflammatory responses
and cause insulin resistance in peripheral tissues. By
contrast, mono- or poly-unsaturated FFAs (MUFAs or
PUFAs) protects against SFAs. Elevated saturated FFAs
can induce inflammation and insulin resistance, through
several mechanisms including diacylglycerol-mediated* Correspondence: algomezh@ucm.es
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creativecommons.org/publicdomain/zero/1.0/activation of protein kinase Cθ [1] and activation of
Toll-like receptors (TLR) [2]. Both mechanisms lead to
the activation of the proinflammatory transcription fac-
tor nuclear factor-kappa B (NF-κB), which has been
linked to fatty acid-induced impairment of insulin action
in skeletal muscle [3, 4]. Once activated, NF-κB regulates
the expression of multiple inflammatory mediators, in-
cluding IL-6, TNF-α and other factors implicated in the
metabolic alterations. IL-6 strongly correlates with insulin
resistance and type 2 diabetes and its plasma levels are in-
creased in patients with obesity and type 2 diabetes [5].
Moreover, NF-κB also regulates the expression of genes
involved in the early and late atherosclerotic process andarticle distributed under the terms of the Creative Commons Attribution
by/4.0), which permits unrestricted use, distribution, and reproduction in any
ly credited. The Creative Commons Public Domain Dedication waiver (http://
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(eNOS), adhesion molecules (e.g. ICAM-1), monocyte
chemotactic protein 1 (MCP-1), and plasminogen activa-
tor inhibitor-1 (PAI-1) [6–8]. On the other hand, activated
NF-κB also might be implicated in JNK-1/2 activation and
induces insulin resistance in several tissues [9].
Various translational studies have identified the differ-
ential role of saturated and unsaturated fatty acids and
their effects at cardiovascular level [10, 11]. MUFAs, as
oleic acid, improve lipid profile [12], maintain a balance
of body weight [13] and prevent palmitate-induced mito-
chondrial dysfunction, insulin resistance and inflamma-
tory signalling in neuronal cells [14] and skeletal muscle
[15]. However, the underlying molecular mechanisms of
the protective role of oleate in cardiovascular cells are
poorly known. Thus, we have studied the protective role
of oleate in insulin resistance and in the early and late
atherosclerotic process and its instability at the cellular
level. To assess this objective, we analyzed the insulin
signalling in cardiovascular cells such as endothelial cells
(ECs), vascular smooth muscle cells (VSMCs) and car-
diomyocyte cells (CMs), the latter two cell lines were
generated by our laboratory. Secondly, we have explored
the differential molecular mechanisms of oleate and palmi-
tate on JNK-1/2 or NF-κB signalling pathways. Further-
more, we analysed the protective role of oleate in the
expression of inflammatory and proatherogenic markers
as well as in the proliferation and apoptosis of VSMCs.
Our data provide a new insight on the differential effect of
oleate versus palmitate giving support to recent findings
that highlight the beneficial effects of oleic acid as an




Primary VSMCs were obtained from thoracic aorta arteries
of three male of 8 week-old wild-type mice. Anesthetized
mice (Avertin, 250 mg/kg, ip) were saline perfused and
thoracic aorta arteries were submitted to collagenase dis-
persion and primary culture as previously described [16].
Other cell line also generated in our laboratory was neo-
natal cardiomyocytes from hearts of eight neonatal mice
(WT CMs). Hearts were dispersed with collagenase type II
(1.2 mg/ml, Whorthington) and treated with DNAsa I,
grade II (10 μg/ml, Roche) at 37 °C for 20 min. Cells were
grown with high glucose DMEM (Life Technologies), Fetal
Bovine Serum (5 %), Horse Serum (10 %), HEPES
(20 mM), cardiotrophin I (R&D Systems 0.2 ng/ml), insu-
lin (1 μM) and a mixture of antibiotics and antifungals.
Cells were seeded in plates pretreated with collagen type I
(Collagen from rat tail, Roche Applied Sciences) to facili-
tate adhesion of cardiomyocytes. So, both primary cultures
of WT VSMCs or WT CMs were infected by retroviralinfection (viral particles containing pBabe retroviral vector
encoding of SV40 Large T antigen) and selected with 1 μg/
mL puromycin for 3 weeks.
Mouse endothelial cells (ECs) were purchased from
ATCC (CRL-2167). These cells were cultured with
high-glucose DMEM (ATCC), with L-glutamine
(4 mM), NaHCO3 (1.5 g/L) and was supplemented
with inactivated Horse Serum (10 %).
Cell lines were cultured with 10 % FBS-DMEM and
were serum-starved for 4–5 h for insulin signaling and
proliferation studies or 18 h for studies of mRNA expres-
sion, and then incubated with the corresponding stimuli.
For in vitro experiments, we have used insulin (1, 10 and
100 nmol/L), TNF-α (10 ng/mL, Sigma), angiotensin II
(1 μmol/L, Sigma), oleic acid (0.6 -1 mmol/L, Sigma) and
palmitic acid (0.4 - 1 μmol/L, Sigma). Moreover, we used
an NF-κB inhibitor as parthenolide (10−5 M for 90 min).
Anna-Maria Ordelheide (Helmholtz Center Munich,
Germany) kindly provided the protocol for the prepar-
ation and dissolution of fatty acids used in this study.
First, a standard solution of palmitic acid (PA, 200 mM
(Sigma)) was dissolved in absolute ethanol and a stand-
ard oleic acid (OA, 100 mM (Sigma)) dissolved in NaOH
solution (0.1 M) was performed. Additionally, a buffer
containing 20 % bovine serum albumin (BSA) / Krebs-
Ringer-HEPES pH 7.4, with which the intermediate fatty
acid solution is prepared to 5 mM. The solution of conju-
gated fatty acids is prepared minutes before experimenta-
tion left stirring at 37 °C until complete dissolution of the
fatty acids are observed to prevent oxidation of these.
Finally, the necessary amount of the conjugate acid
(5 mM)-20 % BSA, the average fatty acid conjugation
which involves low glucose DMEM, BSA (2.5 %) and
FBS (0.5 %) is added. This protocol maintain the pro-
portions 5:1 BSA-fatty acid which allows adequate trans-
port and bioavailability of the fatty acid to the cell. In all
control cells, we used BSA (2.5 %) and FBS (0.5 %) to be
able to compare with OA/PA stimulations.
Western blot
Western blot analyses were performed on protein extracts
from CMs, ECs and VSMCs as previously described [17].
The antibodies used were, SV40 TAg and IκBα from Santa
Cruz Biotechnology, p53 and TnT from Calbiochem,
phospho-AKT (T308), AKT, p-p70S6K (Ser389), p70S6K,
p-AMPK (T172), AMPK, p-JNK-1/2 (T183/Y185), Cleaved
Caspase 3, p-p42/44 (S202/T204) and p42/44 from Cell
Signalling, p-IRS-1 from Millipore and p-Tyr, PAI-1, α-
and β-actin and α-tubulin from Sigma Corp.
Immunoprecipitation
To obtain total cell lysates, cells from supernatants were
collected by centrifugation at 2000 × g for 5 min at 4 °C.
Attached cells were scrapped off in ice-cold PBS, pelleted
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pended in lysis buffer. Samples of cell lysates of VSMCs
were sonicated 30 s at 1.5 mA, and lysates were clarified
by centrifugation at 12,000 × g for 10 min. For immuno-
precipitation, 150–200 μg of protein were immunoprecipi-
tated at 4 °C with the IRS-1 antibody and isotype control
serum. The immune complexes were collected on protein
A-agarose and submitted to SDS-PAGE to check its phos-
phorylation in Tyr and Ser residues.
Proliferation assays
Briefly, 104 cells in 1 mL of complete medium were seeded
into each well of an uncoated 96-well plate. The following
day, the cells were serum deprived for 5 h and stimulated
with TNF-α, angiotensin II or palmitate for 24 h with or
without pretreatment with oleic acid for 2 h. After that,
the rate of cellular proliferation was evaluated using a cell
proliferation ELISA BrdU kit (Roche Applied Science).
The incubation with BrdU labeling solution was for 18 h.
Cell cycle
After treating cells in culture with the corresponding
stimulus, the supernatant cells were collected and the
attached cells were lifted with trypsin. The cells were
centrifuged (5 min, 110 × g, 4 °C) and washed twice
with PBS. The precipitate containing the cells was re-
suspended in 300 μl of ice-cold PBS, and added 700 μl
of absolute ethanol at −20 °C, for fixing for one minute.
Then the cells were washed twice with cold PBS. Cells
were then incubated with 500 μl of warm PBS with
RNase (Roche) for 30 min at 37 °C. Finally, 25 μl of
propidium iodide (PI) (Sigma, 0.1 % (w/v)) in PBS were
added. Cellular DNA content by PI incorporation was
assessed (fluorescent emission between 562 and 588 nm)
and can differentiate apoptotic cells (<2n), cells in the G0/
G1, and cell proliferation (phase S / G2-M, > 2n). For this
a FACScalibur cytometer and Cell Quest Pro software
(Becton Dickinson) was used.
Immunofluorescence
Cells were seeded at low density on circular crystals of
1 cm in diameter. Once treatment is completed, the cells
were washed once with PBS and fixed with paraformalde-
hyde solution (4 % w/v), for 10 min at room temperature.
Then washed with PBS, and incubated 5 min at room
temperature with Triton X-100 (0.2 % v/v) in PBS in order
to permeabilize the cells and permit labeling of intracellu-
lar antigens. To cushion the cellular autofluorescence, the
cells were washed and incubated with a solution of NH4Cl
(50 mM) for 15 min. at room temperature. After further
washing, the nonspecific binding sites are blocked by in-
cubation in a blocking solution of BSA (1 % w/v), 0.2 %
Triton X-100 (v/v) in PBS supplemented with Tween-20
(0.05 % w/v) (PBST) for 45 min at room temperature.Incubation with primary antibodies was performed for
1.5 h at room temperature in a humid chamber. After
washing with PBST, we incubated with secondary anti-
body for 45 min. After a final washing with PBST, the
preparations were mounted on a slide with SlowFade
mounted liquid Gold (Life Technologies) containing
DAPI to visualize nuclei. Samples were generally ob-
served to stabilize the following mounting liquid day,
although stable preparations are stored at 4 °C in the
dark for several weeks.
RNA Extraction and Real-Time Quantitative Polymerase
Chain Reaction
Total RNA was extracted from ECs by TRIzol method
(Invitrogen, Barcelona, Spain) and quantified by absorb-
ance at 260 nm in duplicate. Twenty nanogram of RNA
were necessary to perform the reverse transcription reac-
tion, for 15 min at 25 °C and 2 h at 37 °C, with the High
Capacity cDNA Archive kit (Applied Biosystems, Foster
City, CA). We evaluated the mRNA expression of genes
involved in vascular dysfunction (eNOS and ICAM-1)
and inflammation (MCP-1) on ECs. Amplification of
GAPDH was used in the same reaction of all samples as
an internal control. Gene-specific mRNA was subse-
quently normalized to GAPDH RNA. Quantitative reverse
transcription-PCR was performed in 7500 Real-Time PCR
device, and the relative quantification was performed
with the Prism 7000 system SDS software (Applied Bio-
systems). The expression of these genes was analyzed
by real-time quantitative PCR as described [17]. Thus,
the amount of target, normalized to endogenous gene
and relative to the control is given by 2-ΔΔCt [ΔCt = Ct
(target gene) – Ct (endogenous gene); ΔΔCt = ΔCt for
any sample - ΔCt for the control].
Statistical analysis
All values are expressed as mean +/− SEM. Data were
analyzed using one-way analysis of variance, followed by
a Bonferroni test if differences were noted (SPSS 15.0
program). The null hypothesis was rejected when the p
value was less than 0.05.
Results
Characterization of cardiovascular cell lines
Firstly, we assured the CMs immortalization by Western
blot analysis of T-antigen and p53 (Fig. 1a). Subsequently,
we demonstrated the presence of the cardiomyocytes
specific protein, troponin T (TnT), by Western blot
and immunofluorescence (Fig. 1b). Moreover, we also
characterized the ECs with CD31 antibody or PECAM-1
(Fig. 1c). By immunofluorescence, we detected the ECs
specific protein, von Willebrand factor (vWF) (Fig. 1d).
Secondly, we analyzed insulin signaling in both cardio-
vascular cell lines. We observed that 10 nmol/L insulin
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5 min. On the other hand, a significant increase of p42/44
(T202/Y204) phosphorylation was activated by 10 nmol/L
insulin (Fig. 1e). Subsequently, an insulin dose–response
curve showed that at 5 min the maximal activation of
AKT was found at 100 nM insulin (Fig. 1f). Moreover,
with the lowest insulin dose (1 nmol/L), the phosphoryl-
ation was induced in AKT and p42/44 at 5 and 10 min in
ECs. A significant increase in AKT phosphorylation was
observed at 10 and 100 nmol/L (Fig. 1g). VSMC lines used
in this work were characterized and its insulin signaling
shown in a previous work [18].
Differential effect of oleic or palmitic acid on the
cardiovascular cell insulin sensitivity
Firstly, we studied the oleate effect on insulin sensitivity.
Thus, cardiomyocytes were treated with oleate at 0.6, 0.8
or 1 mmol/L for 2 h before insulin stimulation. We ob-
served that insulin stimulation significantly increased Akt
phosphorylation for each dose of oleate used. Under theFig. 1 Characterization of cardiovascular lines. a Western blot analysis again
cardiomyocyte lines. β-actin was used as charge control. b Characterization
blot or by immunofluorescence. Characterization of ECs with specific markers a
(d). Western blot analysis of insulin signalling in CMs (e, f) and in ECs (g). *p < 0same conditions, Akt activation was accompanied by the
inactivation of AMPK phosphorylation (Fig. 2a). However,
we observed AMPK activation in absence of insulin
(Fig. 2a). In vascular cells, 0.8 mmol/L oleate did not pre-
vent Akt, p42/44 and p70S6K phosphorylation or AMPK
dephosphorylation in response to insulin (Fig. 2b, c). In
addition, oleate induced AMPK activation in the absence
of insulin in vascular cells (Fig. 2b, c). Overall, oleate treat-
ment for 2 h did not produce insulin resistance in the car-
diovascular cells studied. These results were confirmed by
the dose–response effect of oleate at 18 h on Akt phos-
phorylation in the presence of insulin (Additional file 1:
Figure S1). At this stage, we confronted these data regard-
ing oleate with palmitate effect on insulin sensitivity.
For that purpose, we chose 0.4 mmol/L palmitate dose
as previously described in myocytes [15]. Palmitate
(0.4 mmol/L) treatment did not prevent Akt or p42/44
phosphorylation induced by insulin for 2 or 6 h in CMs.
However, prolonged palmitate treatment for 18 or 24 h in-
duced insulin resistance (Additional file 2: Figure S2). Atst AgT and p53 to check the immortalization performed in neonatal
of neonatal cardiomyocytes with a specific marker as TnT by Western
s PECAM-1 or CD31 by flow cytometry (c) or vWF by immunofluorescence
.05 vs. control
Fig. 2 Oleate did not induce cardiovascular insulin resistance. Western blot analysis of phosphorylation de Akt (T308), AMPK (T172), p42/44 (T202/
Y204) and p70S6K (T389) induced by insulin (10nM, 10 min) in presence or absence of oleate (2 h) in CMs (a), ECs (b) and VSMCs (c). β-actin was
used as charge control. *p < 0.05 vs. control
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duced insulin resistance as revealed by Akt, p42/44 and
p70S6K phosphorylation in response to insulin in all the
vascular cells studied (Fig. 3).
We also demonstrate that TNF-α at 2 h induced vas-
cular insulin resistance as palmitate did at 18 h (Fig. 4).
The pretreatment with oleate prevented the inhibition
by TNF-α or palmitate on Akt phosphorylation induced
in response to insulin in cardiovascular cells (Fig. 4). Be-
side the previously proposed mechanism, according to
which oleate may be protecting against cardiovascular
damage induced by TNF-α by UCP-2 expression [19],
we studied the NF-κB signaling pathway. Thus, we ob-
served that TNF-α as well as palmitate increased JNK1/2
phosphorylation in all the vascular cells studied. How-
ever, the pretreatment with oleate reduced JNK phos-
phorylation induced by TNF-α or palmitate (Fig. 5a).
When JNK1/2 was activated by TNF-α, there was an in-
crease in IRS-1 serine phosphorylation and a decrease in
IRS-1 tyrosine phosphorylation. Pretreatment with oleateprevented serine phosphorylation and maintained Tyr
phosphorylation on IRS-1 induced by TNF-α or palmitate
(Fig. 5b). Another mechanism that might be modulated by
oleate, could be mediated by NF-κB. Thus, we observed
that TNF-α, from 10 to 30 min and palmitate at 30 min
were able to reduce the levels of IκB-α (Fig. 5c). Subse-
quently, we observed that oleate was able to partially
prevent IκB-α degradation induced by TNF-α or palmi-
tate. More importantly, parthenolide, an inhibitor of NF-κB
[20], prevented IκB-α degradation induced by TNF-α
(Fig. 5d) and precluded insulin resistance on Akt phosphor-
ylation induced by TNF-α or palmitate in VSMCs (Fig. 5e).
Protective role of oleate in the endothelial dysfunction
markers and in the inflammatory response
We decided to study the effect of several cytokines in-
volved in the inflammatory process, such as TNF-α, IL-6
and IL-1β on some markers of endothelial dysfunction
and activation in ECs and the possible protective effect
of the oleate against those stimuli.
Fig. 3 Palmitate induced cardiovascular insulin resistance. Western blot analysis (a) and its quantifications (b) of Akt phosphorylation (T308), p42/44
(T202/Y204) and p70S6K (T389) induced by insulin (10nM, 10 min) in presence or absence of oleate (2 h) in CMs, ECs and VSMCs. β-actin was used as
charge control. *p < 0.05 vs. control; †p < 0.05 vs. stimulus
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vented eNOS mRNA reduction induced by TNF-α, IL-6
or IL-1β in ECs (Fig. 6a). We also observed that the pre-
treatment with oleate significantly reduced ICAM-1, and
MCP-1 expression induced by the pro-inflammatory cyto-
kines in ECs (Fig. 6b, c).
Protective effect of the oleate on the VSMCs proliferation
One of the factors that contribute to the early growth of
atherosclerotic plaque is the migration and proliferation
of VSMCs. On this regard, pretreatment with oleate
mostly prevented the rate of proliferation induced by
TNF-α, Ang II or palmitate (Fig. 7).
Protective effect of oleate on the VSMCs apoptosis
One of the described mechanisms and directly involved
in the instability and rupture of atherosclerotic plaque, is
the increase of fibrous cap VSMCs apoptosis, weakeningit and triggering the acute event [21, 22]. For this purpose,
we explored if oleate could improve the plaque stability,
reducing VSMCs apoptosis. First, we observed that the
treatment with TNF-α significantly increased the percent-
age of cells in G0/G1 phase in comparison to the control.
In addition, oleate per se does not alter the cellular cycle
in VSMCs. More importantly, the pre-treatment with ole-
ate significantly reduced the percentage of apoptotic cells
induced by TNF-α (Fig. 8a). On this regard, we analysed
active caspase-3 protein levels induced by several stimuli.
As a positive control of apoptosis, we used 1 μg/ml thapsi-
gargin for 30 min that induced a high expression of active
caspase-3. Thus, TNF-α increased the expression of active
caspase-3 as compared with the control. In the presence
of oleate, the expression of caspase-3 induced by TNF-α
was significantly impaired (Fig. 8b). In addition, oleate
also impaired active caspase-3 levels induced by thap-
sigargin (Fig. 8c). However, palmitate did not show
Fig. 4 Oleate protected cardiovascular insulin resistance induced by TNF-α or palmitate. Western blot analysis of phosphorylation of Akt (T308)
induced by insulin (10nM, 10 min) and /or palmitate (0.4 mM, 18 h) or TNF-α (10 ng/mL, 2 h) in presence or absence of oleate in CMs, ECs and
VSMCs. β-actin was used as charge control. *p < 0.05 vs. control; †p < 0.05 vs. stimulus
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caspase-3 induced by thapsigargin. Conversely, oleate
impaired the rate of apoptosis induced by thapsigar-
gin in the presence of palmitate (Fig. 8c).
Protective effect of oleate on thrombogenesis in vascular
cells
Elevated levels of PAI-1 are associated with increased
cardiovascular and thrombotic events [23]. On this re-
gard, TNF-α induces the expression of PAI-1 between 18
and 24 h in VSMCs (Fig. 8d). At this stage, we explored
whether or not TNF-α could be increasing the produc-
tion of PAI-1 in VSMCs through the activation of NF-
κB. For this purpose, we observed that when VSMCs
were pretreated with parthenolide and therefore NF-κB
pathway was inhibited, the production of PAI-1 induced
by TNF-α was partially reduced (Fig. 8e). Next, we de-
cided to explore the effect of oleate on the expression of
PAI-1 induced by TNF-α in VSMCs. First, we observed
that oleate per se did not increase PAI-1 protein levels.
However, treatment with oleate mostly prevented the
elevation of PAI-1 induced by TNF-α (Fig. 8e).
Discussion
Over the past decades, the prevalence of obesity and
metabolic syndrome (MetS), and its underlying risk of
developing cardiovascular disease (CVD), has increased
worldwide becoming a public health problem [24]. It is
known that subjects with MetS have an increased risk of
developing type 2 diabetes, in turn, these people tend tobe overweight or obese, with high levels of circulating
FFA. This increase contributes to the complications of
obesity, such as insulin resistance, excessive fat accumula-
tion in peripheral tissues [25] and alterations in cardiac
function [26, 27], among others. Additionally, increased
levels of circulating FFAs are recognized as a predictor of
myocardial infarction [28].
FFAs may act as either pro- or anti-inflammatory agents
depending on the chemical structure [29]. SFAs, such as
palmitic acid, have been associated with adverse cardio-
vascular effects [30, 31]. However, PUFAs, such omega-3
FAs, improve triglyceride levels and reduce the risk of
CVD by their anti-inflammatory properties [28]. More-
over, it has recently been reported that there is not associ-
ation between dietary omega-3 FA and the risk of MetS
[32]. Similarly to PUFAs, MUFAs, such as oleic acid, has
been associated with antiproliferative effects on cancer
and decreased risk of CVD [13, 33]. Translational studies
as PREDIMED have recommended from Mediterranean
diet, the use of virgin olive oil where its main fatty acid is
oleate due to decreased CVD and improve irrigation in
the treatment of Type 2 Diabetes Mellitus [10, 33]. How-
ever, the molecular mechanisms by which oleate exerts its
protective role in vascular cells is not fully understood.
Our results show that oleate has a differential beneficial
cardiovascular effect with respect to other SFAs as palmi-
tate. So far the evidence pointed to the long-chain SFA
palmitate induced insulin resistance in tissues such as
adipocytes and skeletal muscle [34, 35]. We showed
that in cardiovascular cells, palmitate also induces insulin
Fig. 5 Modulation of JNK-1/2 and NF-κB pathway by oleate. a Western blot analysis of JNK-1/2 phosphorylation in CMs, ECs and VSMCs. b Effect
of oleate in the Ser and Tyr phosphorylation of IRS-1 in VSMCs. Effect of TNF-α or palmitate in IκBα levels in absence (c) or presence (d) of oleate
in VSMCs. e Effect of parthenolide in the phosphorylation of Akt in VSMCs. β-actin was used as charge control
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strated that SFAs stimulated the fatty-acid uptake in detri-
ment of glucose assimilation in cardiomyocytes [36] and
in vivo, SFAs intake is associated with most cardiac re-
modeling [37]. However, we have shown that oleate did
not generate insulin resistance in any studied cardio-
vascular cell lines. Similarly to our results in cardiovascu-
lar cells, oleate was also able to prevent insulin resistance
in the myotubes through activation of PI3K [35] or by a
mechanism dependent of AMPK [15]. In addition, in the
pancreatic β-cells, it has been described that oleate in-
duced activation PI3K and PKB pathway and prevented
apoptosis [38]. On the other hand, other authors have
described that both oleate and palmitate induced insulin
resistance in primary hepatocytes, associated with the
accumulation of dyacilglycerols and/or ceramide [39] or
a diet rich in UFAs increased total adiposity without
impairing cardiovascular parameters [40].
In the present work, we have shown that oleate did
not induce insulin resistance in the context of cardiovas-
cular cells and moreover it is capable of protecting against
insulin resistance induced by palmitate or TNF-α. Justrecently, we proposed that oleate induced an increase
of UCP-2 levels and this might be one of the mechanisms
by which oleate protects against the deleterious action of
palmitate on vascular cells [19]. Additionally, we have now
hypothesized that palmitate or TNF-α could be activating
different pathways such as JNK and NF-κB in cardiovascu-
lar cells. One of the mechanisms that may be involved in
the deleterious effects of SFAs is that they can act as
ligands for TLR, and activate different signaling path-
ways involved in the inflammatory response [41, 42].
Thus, it has been described that palmitate through
TLR2 may induce insulin resistance in myotubes, in-
ducing activation of NF-κB, JNK and p38 [2] and the
impairment of vasodilator actions of insulin [43]. In
our work, both palmitate and TNF-α activated JNK
pathway in all three cardiovascular cell lines. However,
pretreatment with oleate substantially decreased acti-
vation of JNK1/2. These results confirm that oleate
prevents insulin resistance avoiding IRS-1 Ser phosphoryl-
ation and maintaining IRS-1 Tyr phosphorylation in
presence of TNF-α or palmitate, favoring the activa-
tion of the PI3K pathway.
Fig. 6 Effect of oleate in eNOS, ICAM-1 and MCP-1 mRNA expression in ECs. qRT-PCR analysis of eNOS (a), ICAM-1 (b) and MCP-1 (c) mRNA expression
induced by TNF-α, IL-6 and IL-1β in presence or absence of oleate in ECs. *p < 0.05 vs. control; †p < 0.05 vs. stimulus
Fig. 7 Effect of oleate in VSMCs proliferation. Rates of proliferation
measured by BrdU incorporation in response to TNF-α, angiotensin II
or palmitate in presence or absence of oleate. *p < 0.05 vs. control;
†p < 0.05 vs. stimulus
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oleate prevents insulin resistance in VSMCs is the modu-
lation of NF-κB activation. We demonstrate that TNF-α
or palmitate activate NF-κB, decreasing the levels of IκB-α
[44]. However, the reduction of NF-κB by oleate might
be implicated in the protective role of oleate against insu-
lin resistance induced by the TNF-α or palmitate. We also
checked that parthenolide, an inhibitor of NF-κB [20],
prevented IκB-α degradation and therefore the activation
and translocation of NF-κB to the nucleus in addition to
prevent insulin resistance induced by TNF-α or palmitate.
In the literature, it has also been described the dif-
ferential correlation among oleate and palmitate with
inflammasomes. Thus, the proinflammatory effect of
SFAs through a caspase-1/ASC/NLRP3-dependent path-
way [45] might justify that SFA-rich diets increase IL-1β
production and other inflammatory processes related to
IL-1β [45, 46]. However, anti-inflammatory actions of
MUFAs prevent activation of NLRP3 inflammasome in-
duced by SFAs in human monocytes/macrophages [47],
supporting the beneficial effects of MUFAs in Mediterra-
nean diet [10]. Moreover, high MUFAs diet or replace-
ment of SFAs for MUFAs induce changes in abdominal
fat distribution, improve insulin sensitivity [48, 49], andpostprandial oxidative stress in patients with metabolic
syndrome [50].
It is known that during processes such as obesity or
atherosclerosis, there are increased levels of proinflam-
matory cytokines such as IL-6 and TNF-α, which are
capable to activate NF-κB in different tissues. At the
same time, this proinflammatory cytokines activate other
Fig. 8 Effect of oleate in VSMCs apoptosis. Effect of oleate in VSMCs apoptosis induced by TNF-α measured by cellular cycle (a) or by Western
blot analysis of active caspase 3 (b) or induced by thapsigargin by Western blot analysis (c). *p < 0.05 vs. control; †p < 0.05 vs. stimulus. d Western
blot analysis of PAI-1 levels induced by TNF-α at different time points. e Effect of oleate and parthenolide in PAI-1 levels induced by TNF-α. β-actin was
used as charge control
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of self-maintaining inflammation [51]. The permanence of
the inflammatory condition in the vasculature can induce
endothelial dysfunction and activation with an increase in
the expression of chemotactic factors and adhesion mole-
cules such as ICAM-1 and VCAM-1 [52]. Thus, our work
suggests that oleate has also a protective role in the activa-
tion and endothelial function in addition to the inflamma-
tory response. These findings correlate with the positive
effect of oleate found in human VSMCs and ECs [53, 54].
TNF-α is capable of activating two opposite mecha-
nisms, cell survival and cell death simultaneously [55, 56].
Thus, we found that TNF-α, but not palmitate, signifi-
cantly induced an increase in the percentage of cells found
in the G0/G1 phase of the cell cycle. However, treatment
with palmitate has a different behavior between the two
vascular lines: decreases the viability of ECs, but favors the
proliferation of VSMCs, and may play an important
role in the initiation and progression of atherosclerosis.
On this regard, saturated, but not unsaturated, fatty acids
induce apoptosis of human coronary artery endothelial
cells via nuclear factor-kappaB activation [57]. On the
other hand, we demonstrated that oleate exerted a pro-
tective role against the proliferation of VSMCs stimu-
lated by TNF-α, Ang II, or palmitate, contributing to
the prevention of the growth of atherosclerotic plaque.Converserly, palmitate induced changes in VSMCs pheno-
type promoting formation of atherosclerotic plaque [31].
Increased apoptosis of VSMCs is one of the mecha-
nisms directly involved in the instability and rupture of
atherosclerotic plaques, and underlying complications
such as thrombosis [22, 23]. We propose that pretreat-
ment with oleate has a protective role against apoptosis
in VSMCs owing to oleate pretreatment significantly
reduced the percentage of apoptotic cells and active
caspase-3 protein levels induced by TNF-α. It has been
previously described that oleate modulates proapoptotic
proteins expression as Bax, caspase-3 and PARP cleavage in
cardiomyocytes [58]. Thus, we confirm that oleate exerts a
protective role against apoptosis in VSMCs, decreasing the
activation of caspase-3, induced by TNF-α or thapsigargin
that induces stress in the endoplasmic reticulum [59].
Elevated levels of PAI-1 are associated with increased
cardiovascular and thrombotic events [23]. We found that
oleate reduces PAI-1 protein levels induced by TNF-α in
VSMCs, and we show that increased PAI-1 induced by
TNF-α is through activation of NF-κB, given that parthe-
nolide decreases PAI-1 levels induced by TNF-α in
VSMCs. We suggest that oleate exerts its protective
effects through inhibition of NF-κB pathway, and also
improves the thrombogenesis promoting the fibrinoly-
sis by inhibition of PAI-1.
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In conclusion, our results show that oleic acid has a bene-
ficial effect at cardiovascular level as compared with
saturated fatty acids such as palmitic acid. Thus, oleate
protects against cardiovascular insulin resistance, improves
endothelial dysfunction, inflammation and finally, reduces
proliferation and apoptosis in VSMCs that may contribute
to an ameliorated atherosclerotic process and its stability.
These processes may be mediated by inhibition of JNK-1/2
and NF-κB pathways.Additional files
Additional file 1: Figure S1. Oleate did not induce vascular insulin
resistance for a long time. Western blot analysis of Akt (T308) phosphorylation
in ECs and VSMCs stimulated with insulin (10nM, 10 min) with or without
oleate (0.6, 0.8 or 1 mM for 18 h). β-actin was used as charge control.
Additional file 2: Figure S2. Effect of palmitate for different times in
insulin signaling in neonatal cardiomyocytes. Representative gels (A) and
its quantifications (B and C) of Western blot analysis of Akt (T308) and
p42/44 (T202/Y204) phosphorylation in cardiomyocytes (CMs) stimulated
with insulin (10nM, 10 min) with or without palmitate (0.4 mM for 2, 6,18
or 24 h). β-actin was used as charge control. *p < 0.05 vs. control; †p < 0.05
vs. stimulus.Abbreviations
AKT: Protein kinase A; CMs: Cardiomyocyte cells; ECs: Endothelial cells;
eNOS: Endothelial nitric oxide synthase; ERK-1/-2: Extracellular signal-
regulated kinase; ICAM-1: Intercellular adhesion molecule 1; iNOS: Inducible
nitric oxide synthase; IRS-1: Insulin receptor substrate 1; MCP-1: Monocyte
chemoattractant protein-1; NF-κB: Nuclear factor kappa B; OA: Oleic acid;
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PCR: Quantitative real time reverse transcription polymerase chain reaction;
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